FREE NEWSLETTER: Econintersect sends a nightly newsletter highlighting news events of the day, and providing a summary of new articles posted on the website. Econintersect will not sell or pass your email address to others per our privacy policy. You can cancel this subscription at any time by selecting the unsubscribing link in the footer of each email.

posted on 08 March 2016

What To Expect From This Bear Market Rally

by Michael E. Lewitt

Money Morning Article of the Week

Stocks rallied for the third straight week in what appears to be a classic bear market rally. Investors should count their good luck and use higher prices as an opportunity to reduce equity exposure or hedge stocks they don't want to sell.

Last week the Dow Jones Industrial Average jumped by 367 points or 2.2% to 17,006.77 while the S&P 500 rose by 52 points or 2.7% to 1999.99. The Nasdaq Composite Index rose 2.8% to 4717.02. The major averages have gained about 10% since their February lows, giving investors hope that the worst is over.

I do not believe it is. Despite some moderately positive economic news last week, the global economy remains depressed and the prospects for significantly higher stock prices are low. Let me explain.

Markets were encouraged by what they interpreted as strong economic data as well as signs that the oil price decline may be over. Friday's jobs report, which was weaker than it looked, convinced them that the U.S. is unlikely to fall into recession this year. Earlier in the week, manufacturing data was modestly better than expected. And most important, oil prices rose sharply last week, teasing the end of the energy collapse.

The Fed will Turn Good News into Bad News Again

Let's assume for the sake of argument that they are correct about all of these factors. The problem with such a scenario is that, with a 4.9% unemployment rate and inflation ticking up toward its 2% target, the Federal Reserve is under increasing pressure to raise interest rates. Weak markets gave the Fed an excuse to delay doing so.

But a combination of better economic data and stable/rising markets makes it more likely that the Fed will increase interest rates sooner rather than later. They are unlikely to move this month but the odds of a June hike are increasing. And as we saw after the Fed raised rates in December, markets do not react well to such moves.

Higher rates would mean a stronger dollar, which would place downward pressure on oil prices and corporate earnings in the U.S. The corporate credit markets have already raised the cost of capital for both investment grade and junk bond borrowers, which will further depress corporate earnings.

In other words, the good news that investors celebrated last week could very quickly turn into bad news. And if investors are wrong and the economy is not all that strong (which is what I believe), they are jumping the gun. Either way, stocks look very risky here and investors should proceed accordingly.

The One Stock to Avoid at All Costs

While many stocks regained some of their early 2016 losses over the last three weeks, one stock that has not is Valeant Pharmaceutical International Inc. (NYSE: VRX). In fact, the VRX story keeps getting uglier and uglier and is reflected in the stock reaching new lows this week before closing at $61.31 per share, down from $80.65 a week before.

The stock collapsed (again) this week after the company made a series of announcements - the return of its CEO J. Michael Pearson from a medical leave, the withdrawal of its 2016 earnings guidance and the departure of another key executive responsible for overseeing two of the company's most important drugs.

It also disclosed a new SEC investigation into its relationship with defunct mail order pharmacy Philidor RX Services. Analysts are questioning with good reason the company's ability to service its $31 billion debt load, a concern that was bolstered by Moody's Investors Service placing the debt on watch for a downgrade.

Anyone looking for good news at VRX is looking in the wrong place. A company built on a toxic combination of debt, drug price hikes, low R&D and a refusal to tell investors the truth is now paying the price. Investors should avoid this stock at all costs.

>>>>> Scroll down to view and make comments <<<<<<

Click here for Historical Investing Post Listing

Make a Comment

Econintersect wants your comments, data and opinion on the articles posted.  As the internet is a "war zone" of trolls, hackers and spammers - Econintersect must balance its defences against ease of commenting.  We have joined with Livefyre to manage our comment streams.

To comment, using Livefyre just click the "Sign In" button at the top-left corner of the comment box below. You can create a commenting account using your favorite social network such as Twitter, Facebook, Google+, LinkedIn or Open ID - or open a Livefyre account using your email address.

You can also comment using Facebook directly using he comment block below.

Econintersect Investing


Print this page or create a PDF file of this page
Print Friendly and PDF

The growing use of ad blocking software is creating a shortfall in covering our fixed expenses. Please consider a donation to Econintersect to allow continuing output of quality and balanced financial and economic news and analysis.

Take a look at what is going on inside of
Main Home
Analysis Blog
Comments on Feyerabend’s ‘Against Method’, Part II
Comments on Feyerabend’s ‘Against Method’, Part III
News Blog
Mom Breaks Down In Tears When Son With Autism Meets Service Dog
Rail Week Ending 15 October 2016 Paints A Negative Economic View
What Is The New Normal For U.S. Growth?
Affordable Care Act And Its Effect On Part-Time Employment
The Speed Of Filling Jobs Is Declining
First Working Eggs Made From Stem Cells Points To Fertility Breakthrough
Infographic Of The Day: Mega Machines
Online Platforms Double Down On TV Programming
A History Of Mars Missions
How Tesla Out Innovates Traditional Carmakers
Schiaparelli's Descent To Mars In Real Time
September 2016 Existing Home Sales Still Not Excellent
September 2016 Leading Economic Index Improves Indicating Moderate Growth Ahead.
Investing Blog
Options Early Assignment - Should You Worry?
The 401k Plan Manager 17 October 2016
Opinion Blog
Prop. 51 Versus A State-Owned Bank: How California Can Save $10 Billion On A $9 Billion Loan
Obama's Middle East Policy Has Been A Complete Failure - Or Has It?
Precious Metals Blog
How Will The Election Outcome Impact Precious Metals?
Live Markets
21Oct2016 Pre-Market Commentary: Wall Street Pointing To A Lower Opening Despite So So Corporate Earnings, Markets May Recover Be Late Afternoon
Amazon Books & More

.... and keep up with economic news using our dynamic economic newspapers with the largest international coverage on the internet
Asia / Pacific
Middle East / Africa
USA Government

Crowdfunding ....



Analysis Blog
News Blog
Investing Blog
Opinion Blog
Precious Metals Blog
Markets Blog
Video of the Day


Asia / Pacific
Middle East / Africa
USA Government

RSS Feeds / Social Media

Combined Econintersect Feed

Free Newsletter

Marketplace - Books & More

Economic Forecast

Content Contribution



  Top Economics Site Contributor TalkMarkets Contributor Finance Blogs Free PageRank Checker Active Search Results Google+

This Web Page by Steven Hansen ---- Copyright 2010 - 2016 Econintersect LLC - all rights reserved